Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
ConcertAI, founded in 2017 and headquartered in Cambridge, Massachusetts, is a leader in clinical artificial intelligence and real-world data products within the healthcare sector. The company specializes in AI-driven solutions and services that optimize clinical trials, provide predictive patient insights, and support commercial healthcare solutions, primarily serving the oncology research and clinical development sectors.
Since its inception, ConcertAI has demonstrated significant growth and attracted substantial investment. The company has successfully raised $320 million across three funding rounds, with its most recent Series C round in March 2022 securing $150 million. This latest funding round valued ConcertAI at $1.9 billion, highlighting the company's strong market position and investor confidence.
ConcertAI's impressive growth trajectory and innovative approach to healthcare AI have positioned it as a notable player in the industry. The company's high Mosaic score of 770, particularly strong in momentum (812) and market (788) categories, further underscores its potential.
While there is currently no official information available regarding ConcertAI's IPO prospects, the company's substantial funding, impressive valuation, and strong market position in the rapidly growing healthcare AI sector make it a company to watch. However, it's important to note that any discussions about a potential IPO for ConcertAI remain speculative at this time.
Investors interested in ConcertAI should keep an eye on the company's continued growth, partnerships, and any official announcements regarding future funding or public offering plans. As always, potential investors should conduct thorough research and consider consulting with financial advisors before making investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While ConcertAI's IPO prospects remain uncertain, investors eager to gain exposure to innovative healthcare AI companies don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in the healthcare technology sector. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry pioneers like ConcertAI before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
